PharmacyCodes



Nifuran en es it fr

Categoria

Nifuran Nombres de marca, Nifuran Analogos

Nifuran Marca los nombres de mezcla

  • No information avaliable

    • Nifuran Formula quimica

    C8H6N4O5

    Nifuran RX enlace

    http://www.rxlist.com/cgi/generic/nitro25m.htm

    Nifuran FDA hoja

    Nifuran MSDS (hoja de seguridad de materiales)

    Nifuran MSDS

    Nifuran Sintesis de referencia

    No hay información disponible

    Nifuran Peso molecular

    238.157 g/mol

    Nifuran Punto de fusion

    263 oC

    Nifuran H2O Solubilidad

    79.5 mg / L

    Nifuran Estado

    Solid

    Nifuran LogP

    -0.04

    Nifuran Formas de dosificacion

    Tableta

    Nifuran Indicacion

    Para el tratamiento de la infección del tracto urinario

    Nifuran Farmacologia

    Nitrofurantoína, un agente antibacteriano nitrofuranos, está disponible en forma microcristalina y macrocristalinas para tratar las infecciones del tracto urinario causada por muchas bacterias gram-negativas y algunas bacterias gram-positivas.

    Nifuran Absorcion

    No hay información disponible

    Nifuran Toxicidad

    No hay información disponible

    Nifuran Informacion de Pacientes

    Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy; however, they should be advised to contact their physician if any unusual symptoms occur during therapy.

    Patients should be advised not to use antacid preparations containing magnesium trisilicate while taking Macrobid.

    Patients should be counseled that antibacterial drugs including Macrobid should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the future.

    Nifuran Organismos afectados

    Gram negativos y algunas bacterias gram positivas